Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Up – Time to Buy?

Oxford BioMedica (OTCMKTS:OXBDF) shares gapped up prior to trading on Tuesday. The stock had previously closed at $6.70, but opened at $7.25. Oxford BioMedica shares last traded at $7.25, with a volume of 600 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock presently has an average rating of “Hold”.

Oxford BioMedica Stock Performance

The business’s 50-day moving average price is $6.80 and its two-hundred day moving average price is $7.59.

Oxford BioMedica Company Profile

Oxford BioMedica plc is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. The company works with biotechnology and pharmaceutical customers to develop, manufacture and test viral vectors and other biological materials used in advanced therapies.

Its capabilities include process and analytical development, clinical and commercial manufacturing, quality control, regulatory support and technology transfer. Oxford BioMedica has particular expertise in lentiviral vectors, which are used to deliver genetic material into cells, and also provides services involving adeno-associated virus and other viral-vector platforms.

Founded in 1995 and headquartered in Oxford, England, the company serves customers internationally across the pharmaceutical and biotechnology industries.